Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr₹-5.48 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹-69 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr
Mar2021₹-114 Cr
Mar2020₹-5.48 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr
Positive
Mar2021 ₹-114 Cr
Negative
Mar2020 ₹-5.48 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,407.2 Cr -8% 6.8% 72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹125,156.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -1.5% 1.7% -5.4% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-8%

6.8%

72.3%

SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses